Derivation and external validation of a simple risk tool to predict 30-day hospital readmissions after transcatheter aortic valve replacement
June 20, 2019 | 10.4244/EIJ-D-18-00954
Showing 1-20 of 33 articles
Derivation and External Validation of a Novel Risk Score for Prediction of 30-Day Mortality After Percutaneous Coronary Intervention
June 11, 2019 | 10.4244/EIJ-D-19-00262
Interventions for heart failure
Pulmonary Artery Denervation Using Catheter based Ultrasonic Energy. May 7, 2019 | 10.4244/EIJ-D-18-01082
Interventions for valvular disease
Derivation and External Validation of a Simple Risk Tool to Predict 30-Day Hospital Readmissions after Transcatheter Aortic Valve Replacement February 26, 2019 | 10.4244/EIJ-D-18-00954
Coronary interventions
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial November 20, 2018 | 10.4244/EIJ-D-18-00711
Interventions for valvular disease
Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model July 20, 2018 | 10.4244/EIJ-D-18-00032
Interventions for valvular disease
Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies March 20, 2018 | 10.4244/EIJ-D-17-00704
Novel radiation dose reduction fluoroscopic technology facilitates chronic total occlusion percutaneous coronary interventions
December 8, 2017 | 10.4244/EIJ-D-16-00216
Interventions for valvular disease
Restorative valve therapy by endogenous tissue restoration: tomorrow’s world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration September 24, 2017 | 10.4244/EIJ-D-17-00509
Coronary interventions
Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES) November 20, 2016 | 10.4244/EIJV12I10A200
Coronary interventions
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial September 18, 2016 | 10.4244/EIJV12I7A141
Interventions for valvular disease
Upcoming TAVI trials: rationale, design and impact on clinical practice September 18, 2016 | 10.4244/EIJV12SYA12
Coronary interventions
In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty system August 20, 2016 | 10.4244/EIJY15M10_01
Coronary interventions
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom™ drug-coated stent vs. the Gazelle™ bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy August 20, 2016 | 10.4244/EIJV12I6A129
Coronary interventions
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment August 5, 2016 | 10.4244/EIJV12I5A102
Coronary interventions
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program July 20, 2016 | 10.4244/EIJY15M07_07
Interventions for valvular disease
VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies June 20, 2016 | 10.4244/EIJV12I3A60
Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index
October 20, 2015 | 10.4244/EIJY14M10_05
Interventions for valvular disease
The Tiara transcatheter mitral valve implantation system September 17, 2015 | 10.4244/EIJV11SWA20
